Company
Verto Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Verto is developing small molecule translation inhibitors for oncology, advancing programs against Myc and other hard-to-drug targets.
Loading relationship preview